OCUL
OCULAR THERAPEUTIX, INC
Company overview
- Market capitalization
- $1.68B
- Employees
- 325
- Latest publication
- 2026-09-29
About OCULAR THERAPEUTIX, INC
Ocular Therapeutix, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States. The company markets DEXTENZA, a dexamethasone ophthalmic insert to treat post-surgical ocular inflammation and pain following ophthalmic surgery, as well as allergic conjunctivitis. It is also developing AXPAXLI, an axitinib intravitreal hydrogel that is in phase 3 clinical trials for the treatment of wet age-related macular degeneration and non-proliferative diabetic retinopathy; OTX-TIC, a travoprost intracameral hydrogel, which has completed phase 2 clinical trials for the treatment of open-angle glaucoma or ocular hypertension. The company has a license agreement and collaboration with AffaMed Therapeutics Limited for the development and commercialization of DEXTENZA and OTX-TIC. Ocular Therapeutix, Inc. was incorporated in 2006 and is headquartered in Bedford, Massachusetts.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q4 20182018-12-31 · USD | Q3 20182018-09-30 · USD | Q2 20182018-06-30 · USD | Q1 20182018-03-31 · USD | Q4 20172017-12-31 · USD | Q3 20172017-09-30 · USD | Q2 20172017-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 13,475,000USD | 504,000USD | 498,000USD | 648,000USD | 340,000USD | 487,000USD | 523,000USD | 438,000USD |
| Cost Of Revenue | 2,011,000USD | 117,000USD | 115,000USD | 153,000USD | 80,000USD | 113,000USD | 125,000USD | 104,000USD |
| Gross Profit | 11,464,000USD | 387,000USD | 383,000USD | 495,000USD | 260,000USD | 374,000USD | 398,000USD | 334,000USD |
| Research Development | 54,138,000USD | 10,258,000USD | 9,685,000USD | 8,745,000USD | 8,227,000USD | 7,908,000USD | 8,126,000USD | 8,117,000USD |
| Selling And Marketing Expenses | 17,276,000USD | 2,291,000USD | 1,067,000USD | 867,000USD | 717,000USD | 903,000USD | 3,238,000USD | 6,832,000USD |
| General And Administrative Expenses | 22,159,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 93,573,000USD | 17,670,000USD | 15,199,000USD | 14,059,000USD | 13,715,000USD | 13,090,000USD | 15,594,000USD | 18,673,000USD |
| Operating Income | -82,109,000USD | -17,283,000USD | -14,816,000USD | -13,564,000USD | -13,455,000USD | -12,716,000USD | -15,196,000USD | -18,339,000USD |
| Total Other Income Expense Net | 3,346,000USD | -116,000USD | -194,000USD | -240,000USD | -310,000USD | -386,000USD | -371,000USD | -355,000USD |
| Interest Expense | 2,792,000USD | 374,000USD | 424,000USD | 455,000USD | 486,000USD | 490,000USD | 491,000USD | 468,000USD |
| Net Income | -78,763,000USD | -17,399,000USD | -15,010,000USD | -13,804,000USD | -13,765,000USD | -13,102,000USD | -15,567,000USD | -18,694,000USD |
| Selling General Administrative | — | 5,121,000USD | 4,447,000USD | 4,447,000USD | 4,771,000USD | 4,279,000USD | 4,230,000USD | 3,724,000USD |
| Income Before Tax | — | -17,399,000USD | -15,010,000USD | -13,804,000USD | -13,765,000USD | -13,102,000USD | -15,567,000USD | -18,694,000USD |
| Income Tax Expense | — | -324,000USD | 230,000USD | 215,000USD | 176,000USD | -424,000USD | 496,000USD | 113,000USD |
| Net Income From Continuing Ops | — | -17,399,000USD | -15,010,000USD | -13,804,000USD | -13,765,000USD | -13,102,000USD | -15,567,000USD | -18,694,000USD |
| Ebit | — | -17,025,000USD | -14,586,000USD | -13,349,000USD | -13,279,000USD | -12,612,000USD | -15,076,000USD | -18,226,000USD |
| Ebitda | — | -16,443,000USD | -14,013,000USD | -12,783,000USD | -12,714,000USD | -12,084,000USD | -14,594,000USD | -17,872,000USD |
| Depreciation And Amortization | — | 582,000USD | 573,000USD | 566,000USD | 565,000USD | 528,000USD | 482,000USD | 354,000USD |
| Reconciled Depreciation | — | 582,000USD | 573,000USD | 566,000USD | 565,000USD | 528,000USD | 482,000USD | 354,000USD |
| Non Operating Income Net Other | — | 258,000USD | 230,000USD | 215,000USD | 176,000USD | 104,000USD | 120,000USD | 113,000USD |
| Minority Interest | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Discontinued Operations | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Net Income Applicable To Common Shares | — | -17,399,000USD | -15,010,000USD | -13,804,000USD | -13,765,000USD | -13,102,000USD | -15,567,000USD | -18,694,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20182018-12-31 · USD | FY 20172017-12-31 · USD | FY 20162016-12-31 · USD | FY 20152015-12-31 · USD | FY 20142014-12-31 · USD | FY 20132013-12-31 · USD | FY 20122012-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Revenue | 1,990,000USD | 1,923,000USD | 1,887,000USD | 1,750,000USD | 772,000USD | — | 10,000USD |
| Cost Of Revenue | 465,000USD | 457,000USD | 443,000USD | 319,000USD | 91,000USD | 10,517,000USD | 7,000USD |
| Gross Profit | 1,525,000USD | 1,466,000USD | 1,444,000USD | 1,431,000USD | 681,000USD | -10,517,000USD | 3,000USD |
| Research Development | 36,915,000USD | 30,880,000USD | 27,065,000USD | 26,611,000USD | 18,880,000USD | 10,517,000USD | 11,540,000USD |
| Selling General Administrative | 18,786,000USD | 15,509,000USD | 11,004,000USD | 9,165,000USD | 6,913,000USD | 1,761,000USD | 1,477,000USD |
| Selling And Marketing Expenses | 4,942,000USD | 17,000,000USD | 6,701,000USD | 3,852,000USD | 1,982,000USD | 625,000USD | 657,000USD |
| Total Operating Expenses | 60,643,000USD | 63,389,000USD | 44,770,000USD | 39,628,000USD | 27,775,000USD | 12,903,000USD | 13,674,000USD |
| Operating Income | -59,118,000USD | -61,923,000USD | -43,326,000USD | -38,197,000USD | -27,094,000USD | -12,903,000USD | -13,671,000USD |
| Interest Income | 879,000USD | 424,000USD | 304,000USD | 1,558,000USD | — | — | — |
| Interest Expense | 1,739,000USD | 1,892,000USD | 1,680,000USD | 1,724,000USD | 1,119,000USD | 441,000USD | 377,000USD |
| Net Interest Income | -860,000USD | -1,468,000USD | -1,376,000USD | — | — | — | — |
| Income Before Tax | -59,978,000USD | -63,386,000USD | -44,703,000USD | -39,748,000USD | -28,648,000USD | -13,317,000USD | -14,093,000USD |
| Income Tax Expense | -2,286,000USD | 272,000USD | 798,000USD | 977,000USD | 130,000USD | 455,000USD | 328,000USD |
| Net Income | -57,692,000USD | -63,386,000USD | -44,703,000USD | -39,748,000USD | -28,648,000USD | -13,317,000USD | -14,093,000USD |
| Net Income From Continuing Ops | -59,978,000USD | -63,386,000USD | -44,703,000USD | -39,748,000USD | -28,648,000USD | — | — |
| Ebit | -58,239,000USD | -61,494,000USD | -43,023,000USD | -38,024,000USD | -27,529,000USD | -12,903,000USD | -13,716,000USD |
| Ebitda | -55,953,000USD | -59,869,000USD | -42,142,000USD | -37,270,000USD | -26,982,000USD | -12,499,000USD | -13,312,000USD |
| Depreciation And Amortization | 2,286,000USD | 1,625,000USD | 881,000USD | 754,000USD | 547,000USD | 404,000USD | 404,000USD |
| Reconciled Depreciation | 2,286,000USD | 1,625,000USD | — | — | — | — | — |
| Total Other Income Expense Net | -860,000USD | -1,463,000USD | -1,377,000USD | -1,551,000USD | -1,554,000USD | -414,000USD | -422,000USD |
| Non Operating Income Net Other | 879,000USD | 429,000USD | 303,000USD | 173,000USD | -435,000USD | — | — |
| Net Income Applicable To Common Shares | -59,978,000USD | -63,386,000USD | -44,703,000USD | -39,748,000USD | -28,659,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 671,317,000USD | 732,529,000USD | 808,057,000USD | 410,882,000USD | 451,333,000USD | 405,920,000USD | 457,935,000USD | 490,369,000USD |
| Cash And Equivalents | 598,641,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 644,427,000USD | 705,995,000USD | 782,129,000USD | 386,980,000USD | 433,375,000USD | 387,694,000USD | 440,987,000USD | 473,011,000USD |
| Other Current Assets | 11,699,000USD | 11,212,000USD | 10,855,000USD | 7,952,000USD | 8,790,000USD | 9,523,000USD | 13,457,000USD | 13,151,000USD |
| Total Liabilities | 151,276,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 49,174,000USD | 47,683,000USD | 50,806,000USD | 49,294,000USD | 42,931,000USD | 37,926,000USD | 41,354,000USD | 36,359,000USD |
| Other Current Liabilities | 39,056,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 931,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 520,041,000USD | 581,574,000USD | 654,310,000USD | 258,228,999USD | 305,916,000USD | 265,930,000USD | 315,344,000USD | 352,021,000USD |
| Total Equity Including Noncontrolling Interest | 520,041,000USD | — | — | — | — | — | — | — |
| Deferred Revenue Non Current | 14,000,000USD | — | — | — | — | — | — | — |
| Net Receivables | 30,261,000USD | 24,347,000USD | 30,650,000USD | 30,768,000USD | 30,412,000USD | 25,221,000USD | 32,388,000USD | 30,235,000USD |
| Inventory | 3,826,000USD | 3,737,000USD | 3,564,000USD | 3,488,000USD | 3,039,000USD | 3,269,000USD | 3,040,000USD | 2,405,000USD |
| Property Plant Equipment Net | 25,276,000USD | 24,920,000USD | 24,314,000USD | 22,288,000USD | 16,344,000USD | 16,612,000USD | 15,334,000USD | 15,744,000USD |
| Accounts Payable | 6,996,000USD | 8,026,000USD | 4,154,000USD | 6,260,000USD | 5,889,000USD | 4,626,000USD | 4,176,000USD | 4,001,000USD |
| Short Term Debt | 3,122,000USD | 3,170,000USD | 2,817,000USD | 2,762,000USD | 2,625,000USD | 2,156,000USD | 1,933,000USD | 1,717,000USD |
| Common Stock | 22,000USD | 22,000USD | 22,000USD | 18,000USD | 17,000USD | 16,000USD | 16,000USD | 16,000USD |
| Retained Earnings | -1,324,398,000USD | -1,245,635,000USD | -1,157,023,000USD | -1,092,369,000USD | -1,022,951,000USD | -955,137,000USD | -891,084,000USD | -842,696,000USD |
| Total Liab | — | 150,955,000USD | 153,747,000USD | 152,653,000USD | 145,417,000USD | 139,990,000USD | 142,591,000USD | 138,348,000USD |
| Other Current Liab | — | 36,486,999USD | 43,835,000USD | 40,272,000USD | 34,417,000USD | 31,080,000USD | 35,117,000USD | 30,451,000USD |
| Capital Stock | — | 22,000USD | 22,000USD | 18,000USD | 17,000USD | 16,000USD | 16,000USD | 16,000USD |
| Other Assets | — | 1USD | — | — | — | — | — | — |
| Cash | — | 666,699,000USD | 737,060,000USD | 344,772,000USD | 391,134,000USD | 349,681,000USD | 392,102,000USD | 427,220,000USD |
| Cash And Short Term Investments | — | 666,699,000USD | 737,060,000USD | 344,772,000USD | 391,134,000USD | 349,681,000USD | 392,102,000USD | 427,220,000USD |
| Current Deferred Revenue | — | 14,000,000USD | — | 14,000,000USD | 14,000,000USD | 64,000USD | 128,000USD | 190,000USD |
| Net Debt | — | -587,237,000USD | -660,092,000USD | -267,764,000USD | -314,195,000USD | -273,457,000USD | -316,319,000USD | -352,096,000USD |
| Short Long Term Debt Total | — | 79,462,000USD | 76,968,000USD | 77,008,000USD | 76,939,000USD | 76,224,000USD | 75,783,000USD | 75,124,000USD |
| Long Term Debt | — | 72,062,000USD | 71,336,000USD | 70,617,000USD | 69,906,000USD | 69,202,000USD | 68,505,000USD | 67,815,000USD |
| Property Plant Equipment Gross | — | 24,920,000USD | 51,834,000USD | 22,288,000USD | 16,344,000USD | 16,612,000USD | 38,966,000USD | 15,744,000USD |
| Common Stock Shares Outstanding | — | 224,099,410shares | 222,921,325shares | 183,919,808shares | 172,594,662shares | 169,396,989shares | 168,019,285shares | 166,993,000shares |
| Non Current Assets Total | — | 26,533,999USD | 25,928,000USD | 23,902,000USD | 17,958,000USD | 18,226,000USD | 16,948,000USD | 17,358,000USD |
| Non Current Liabilities Total | — | 103,272,000USD | 102,941,000USD | 103,359,000USD | 102,486,000USD | 102,064,000USD | 101,237,000USD | 101,989,000USD |
| Non Current Liabilities Other | — | 909,000USD | 887,000USD | 151,000USD | 148,000USD | 144,000USD | 141,000USD | 117,000USD |
| Non Currrent Assets Other | — | -1USD | 1,614,000USD | 1,614,000USD | 1,614,000USD | 1,614,000USD | 1,614,000USD | 1,614,000USD |
| Net Working Capital | — | 658,312,000USD | 731,323,000USD | 337,686,000USD | 390,444,000USD | 349,768,000USD | 399,633,000USD | 436,652,000USD |
| Unclassified Non Current Assets | — | 1,613,998USD | — | — | — | — | — | — |
| Unclassified Current Liabilities | — | -13,999,999USD | — | -14,000,000USD | -14,000,000USD | — | — | — |
| Unclassified Non Current Liabilities | — | 30,301,000USD | 30,718,000USD | 32,591,000USD | 32,432,000USD | 32,718,000USD | 32,591,000USD | 34,057,000USD |
| Unclassified Equity | — | 1,827,165,000USD | 1,811,289,000USD | 1,350,561,999USD | 1,328,833,000USD | 1,221,035,000USD | 1,206,396,000USD | 1,194,685,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 808,057,000USD | 457,935,000USD | 252,060,000USD | 149,289,000USD | 204,887,000USD | 261,863,000USD | 78,740,000USD | 73,043,000USD |
| Other Current Assets | 10,855,000USD | 13,457,000USD | 7,944,000USD | 4,028,000USD | 4,751,000USD | 4,650,000USD | 2,231,000USD | 3,426,000USD |
| Total Liab | 153,747,000USD | 142,591,000USD | 160,929,000USD | 113,910,000USD | 116,888,000USD | 185,768,000USD | 82,370,000USD | 37,168,000USD |
| Total Stockholder Equity | 654,310,000USD | 315,344,000USD | 91,131,000USD | 35,379,000USD | 87,999,000USD | 76,095,000USD | -3,630,000USD | 35,875,000USD |
| Other Current Liab | 43,835,000USD | 35,117,000USD | 28,666,000USD | 24,097,000USD | 20,121,000USD | 14,307,000USD | 7,635,000USD | 6,194,000USD |
| Common Stock | 22,000USD | 16,000USD | 12,000USD | 8,000USD | 8,000USD | 8,000USD | 5,000USD | 4,000USD |
| Capital Stock | 22,000USD | 16,000USD | 12,000USD | 8,000USD | 8,000USD | 8,000USD | 5,000USD | 4,000USD |
| Retained Earnings | -1,157,023,000USD | -891,084,000USD | -697,578,000USD | -616,842,000USD | -545,804,000USD | -539,251,000USD | -383,615,000USD | -297,243,000USD |
| Cash | 737,060,000USD | 392,102,000USD | 195,807,000USD | 102,300,000USD | 164,164,000USD | 228,057,000USD | 54,437,000USD | 54,062,000USD |
| Cash And Short Term Investments | 737,060,000USD | 392,102,000USD | 195,807,000USD | 102,300,000USD | 164,164,000USD | 228,057,000USD | 54,437,000USD | 54,062,000USD |
| Total Current Assets | 782,129,000USD | 440,987,000USD | 232,235,000USD | 129,627,000USD | 191,300,000USD | 246,160,000USD | 60,170,000USD | 56,193,000USD |
| Total Current Liabilities | 50,806,000USD | 41,354,000USD | 34,896,000USD | 31,395,000USD | 26,337,000USD | 26,664,000USD | 12,029,000USD | 9,159,000USD |
| Current Deferred Revenue | 14,000,000USD | 128,000USD | 255,000USD | 576,000USD | 13,000,000USD | 12,000,000USD | — | — |
| Net Debt | -657,277,000USD | -316,319,000USD | -112,418,000USD | -38,017,000USD | -105,181,000USD | -169,618,000USD | 4,906,000USD | -29,274,000USD |
| Short Term Debt | 2,817,000USD | 1,933,000USD | 1,586,000USD | 1,599,000USD | 1,624,000USD | 9,648,000USD | 1,126,000USD | — |
| Short Long Term Debt Total | 79,783,000USD | 75,783,000USD | 83,389,000USD | 64,283,000USD | 58,983,000USD | 58,439,000USD | 59,343,000USD | 24,788,000USD |
| Long Term Debt | 71,336,000USD | 68,505,000USD | 74,925,000USD | 54,006,000USD | 51,435,000USD | 41,243,000USD | 49,312,000USD | 24,788,000USD |
| Net Receivables | 30,650,000USD | 32,388,000USD | 26,179,000USD | 21,325,000USD | 21,135,000USD | 12,252,000USD | 2,548,000USD | 201,000USD |
| Inventory | 3,564,000USD | 3,040,000USD | 2,305,000USD | 1,974,000USD | 1,250,000USD | 1,201,000USD | 954,000USD | 217,000USD |
| Accounts Payable | 4,154,000USD | 4,176,000USD | 4,389,000USD | 5,123,000USD | 4,592,000USD | 2,709,000USD | 3,268,000USD | 2,965,000USD |
| Property Plant Equipment Net | 24,314,000USD | 15,334,000USD | 18,211,000USD | 17,898,000USD | 11,823,000USD | 13,939,000USD | 16,806,000USD | 10,236,000USD |
| Property Plant Equipment Gross | 51,834,000USD | 38,966,000USD | 38,471,000USD | 17,898,000USD | 11,823,000USD | 13,939,000USD | 16,806,000USD | 10,236,000USD |
| Common Stock Shares Outstanding | 187,241,483shares | 158,265,000shares | 85,596,594shares | 82,644,267shares | 82,162,102shares | 60,752,225shares | 45,273,231shares | 38,115,142shares |
| Non Current Assets Total | 25,928,000USD | 16,948,000USD | 19,825,000USD | 19,662,000USD | 13,587,000USD | 15,703,000USD | 18,570,000USD | 16,850,000USD |
| Non Current Liabilities Total | 102,941,000USD | 101,237,000USD | 126,033,000USD | 82,515,000USD | 90,551,000USD | 159,104,000USD | 70,341,000USD | 28,009,000USD |
| Non Current Liabilities Other | 887,000USD | 141,000USD | 108,000USD | 22,158,000USD | 18,924,000USD | 19,548,000USD | 8,905,000USD | — |
| Non Currrent Assets Other | 1,614,000USD | 1,614,000USD | 1,614,000USD | 1,764,000USD | 1,764,000USD | 1,764,000USD | 1,764,000USD | 6,614,000USD |
| Net Working Capital | 731,323,000USD | 399,633,000USD | 197,339,000USD | 98,232,000USD | 164,963,000USD | 219,496,000USD | 48,141,000USD | 47,034,000USD |
| Unclassified Current Liabilities | -14,000,000USD | — | — | — | -13,000,000USD | -20,290,000USD | — | — |
| Unclassified Non Current Liabilities | 30,718,000USD | 32,591,000USD | 51,000,000USD | -19,831,000USD | -33,192,000USD | -110,313,000USD | -12,124,000USD | -3,221,000USD |
| Unclassified Equity | 1,811,289,000USD | 1,206,396,000USD | 788,685,000USD | 652,205,000USD | 633,787,000USD | 615,330,000USD | 389,994,000USD | 340,737,000USD |
| Other Assets | — | — | 1USD | 1,764,000USD | 1,764,000USD | 7,608,000USD | 1,764,000USD | 6,614,000USD |
| Deferred Long Term Liab | — | — | — | 6,351,000USD | 20,192,000USD | 98,313,000USD | 12,124,000USD | 3,221,000USD |
| Other Liab | — | — | — | 19,831,000USD | 33,192,000USD | 110,313,000USD | 12,124,000USD | 3,221,000USD |
| Net Tangible Assets | — | — | — | 35,379,000USD | 87,999,000USD | 76,095,000USD | -3,630,000USD | 35,875,000USD |
| Unclassified Non Current Assets | — | — | — | -1,764,000USD | -1,764,000USD | -7,608,000USD | -1,764,000USD | -6,614,000USD |
| Short Long Term Debt | — | — | — | — | — | 8,290,000USD | — | — |
| Accumulated Other Comprehensive Income | — | — | — | — | — | — | -10,019,000USD | -7,627,000USD |
| Unclassified Current Assets | — | — | — | — | — | — | — | -1,713,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -88,612,000USD | -64,654,000USD | -69,418,000USD | -67,814,000USD | -64,053,000USD | -48,388,000USD | -36,493,000USD | -43,777,000USD |
| Depreciation | 1,283,000USD | 1,247,000USD | 1,069,000USD | 1,026,000USD | 981,000USD | 951,000USD | 959,000USD | 956,000USD |
| Stock Based Compensation | 15,582,000USD | 11,359,000USD | 11,691,000USD | 9,678,000USD | 10,456,000USD | 7,197,000USD | 6,641,000USD | 11,293,000USD |
| Other Non Cash Items | 4,792,000USD | -100,000USD | 2,205,000USD | 1,320,000USD | 2,414,000USD | -47,000USD | -6,455,000USD | 3,596,000USD |
| Change To Account Receivables | 6,303,000USD | 118,000USD | -356,000USD | -5,191,000USD | 7,167,000USD | -2,153,000USD | -3,000USD | -3,686,000USD |
| Change To Inventory | -173,000USD | -76,000USD | -449,000USD | 230,000USD | -229,000USD | -635,000USD | 142,000USD | 27,000USD |
| Change In Working Capital | 962,000USD | -2,101,000USD | 3,728,000USD | 552,000USD | 5,531,000USD | 858,000USD | -1,211,000USD | 3,130,000USD |
| Total Cash From Operating Activities | -65,993,000USD | -54,249,000USD | -50,725,000USD | -55,238,000USD | -44,671,000USD | -39,429,000USD | -36,559,000USD | -24,802,000USD |
| Capital Expenditures | -4,662,000USD | -2,839,000USD | -5,993,000USD | -1,245,000USD | -1,933,000USD | -202,000USD | -89,000USD | -742,000USD |
| Free Cash Flow | -70,655,000USD | -57,088,000USD | -56,718,000USD | -56,483,000USD | -46,604,000USD | -39,631,000USD | -36,648,000USD | -25,544,000USD |
| Total Cashflows From Investing Activities | -4,662,000USD | -2,839,000USD | -5,993,000USD | -1,115,000USD | -1,933,000USD | -202,000USD | -89,000USD | -742,000USD |
| Total Cash From Financing Activities | 294,000USD | 449,376,000USD | 10,356,000USD | 97,806,000USD | 4,183,000USD | 4,513,000USD | 4,178,000USD | 2,196,000USD |
| Change In Cash | -70,361,000USD | 392,288,000USD | -46,362,000USD | 41,453,000USD | -42,421,000USD | -35,118,000USD | -32,470,000USD | -23,348,000USD |
| Begin Period Cash Flow | 738,674,000USD | 346,386,000USD | 391,134,000USD | 351,295,000USD | 393,716,000USD | 428,834,000USD | 461,304,000USD | 484,652,000USD |
| End Period Cash Flow | 668,313,000USD | 738,674,000USD | 344,772,000USD | 392,748,000USD | 351,295,000USD | 393,716,000USD | 428,834,000USD | 461,304,000USD |
| Other Cashflows From Financing Activities | 294,000USD | — | 10,356,000USD | 3,068,000USD | 4,183,000USD | 3,989,000USD | 4,178,000USD | 1,704,000USD |
| Issuance Of Capital Stock | — | 446,439,000USD | 0USD | 94,738,000USD | 0USD | 524,000USD | 0USD | 492,000USD |
| Investments | — | — | -5,993,000USD | -1,115,000USD | -1,933,000USD | -202,000USD | -89,000USD | -742,000USD |
| Unclassified Investing Cash Flow | — | — | 5,993,000USD | 1,115,000USD | 1,933,000USD | — | — | — |
| Sale Purchase Of Stock | — | — | — | 713,000USD | — | — | 492,000USD | — |
| Other Cashflows From Investing Activities | — | — | — | 130,000USD | — | — | — | — |
| Unclassified Financing Cash Flow | — | — | — | 94,025,000USD | — | — | — | — |
| Net Borrowings | — | — | — | — | — | 0USD | 0USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20172017-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -265,939,000USD | -193,506,000USD | -80,736,000USD | -71,038,000USD | -6,553,000USD | -155,636,000USD | -86,372,000USD | -63,386,000USD |
| Depreciation | 4,323,000USD | 3,786,000USD | 2,983,000USD | 2,109,000USD | 2,421,000USD | 2,773,000USD | 2,530,000USD | 1,625,000USD |
| Stock Based Compensation | 43,184,000USD | 33,109,000USD | 17,825,000USD | 16,964,000USD | 14,977,000USD | 7,531,000USD | 8,759,000USD | 7,321,000USD |
| Other Non Cash Items | 5,839,000USD | 32,164,000USD | -2,895,000USD | -8,987,000USD | 4,628,000USD | 4,414,000USD | 3,683,000USD | 408,000USD |
| Change To Account Receivables | 1,738,000USD | -6,209,000USD | -4,854,000USD | -190,000USD | -8,883,000USD | -9,704,000USD | -2,347,000USD | 24,000USD |
| Change To Inventory | -524,000USD | -735,000USD | -331,000USD | -724,000USD | -49,000USD | -247,000USD | -737,000USD | -9,000USD |
| Change In Working Capital | 7,710,000USD | -10,230,000USD | -7,411,000USD | 1,349,000USD | -2,901,000USD | 1,175,000USD | -1,875,000USD | 3,550,000USD |
| Total Cash From Operating Activities | -204,883,000USD | -134,677,000USD | -70,234,000USD | -59,603,000USD | -65,550,000USD | -53,554,000USD | -77,578,000USD | -50,473,000USD |
| Capital Expenditures | -12,010,000USD | -1,288,000USD | -6,087,000USD | -3,715,000USD | -1,194,000USD | -841,000USD | -2,238,000USD | -8,252,000USD |
| Free Cash Flow | -216,893,000USD | -135,965,000USD | -76,321,000USD | -63,318,000USD | -66,744,000USD | -54,395,000USD | -79,816,000USD | -58,725,000USD |
| Total Cashflows From Investing Activities | -11,880,000USD | -1,288,000USD | -6,087,000USD | -3,715,000USD | -1,194,000USD | -841,000USD | -2,238,000USD | 27,067,000USD |
| Net Borrowings | 0USD | 0USD | 56,349,000USD | 0USD | -445,000USD | -445,000USD | 37,275,000USD | 2,400,000USD |
| Total Cash From Financing Activities | 561,721,000USD | 332,110,000USD | 169,828,000USD | 1,454,000USD | 2,851,000USD | 228,014,000USD | 75,341,000USD | 32,008,000USD |
| Sale Purchase Of Stock | 1,592,000USD | 1,016,000USD | 851,000USD | 940,000USD | 985,000USD | 747,000USD | 451,000USD | 276,000USD |
| Issuance Of Capital Stock | 541,177,000USD | 316,353,000USD | 9,532,000USD | 8,824,000USD | 985,000USD | 224,682,000USD | 37,537,000USD | — |
| Change In Cash | 344,958,000USD | 196,145,000USD | 93,507,000USD | -61,864,000USD | -63,893,000USD | 173,620,000USD | -4,475,000USD | 8,602,000USD |
| Begin Period Cash Flow | 393,716,000USD | 197,571,000USD | 104,064,000USD | 165,928,000USD | 229,821,000USD | 56,201,000USD | 60,676,000USD | 32,936,000USD |
| End Period Cash Flow | 738,674,000USD | 393,716,000USD | 197,571,000USD | 104,064,000USD | 165,928,000USD | 229,821,000USD | 56,201,000USD | 41,538,000USD |
| Other Cashflows From Investing Activities | 130,000USD | — | — | -3,715,000USD | — | — | — | 114,000USD |
| Other Cashflows From Financing Activities | 561,721,000USD | -300,596,000USD | -4,633,000USD | 514,000USD | 7,018,000USD | 6,533,000USD | 529,000USD | 370,000USD |
| Investments | — | -1,288,000USD | -7,778,000USD | -3,715,000USD | -1,194,000USD | -841,000USD | -2,238,000USD | 35,200,000USD |
| Unclassified Investing Cash Flow | — | 1,288,000USD | 7,778,000USD | 7,430,000USD | 1,194,000USD | — | 2,238,000USD | — |
| Unclassified Financing Cash Flow | — | 631,690,000USD | 169,828,000USD | — | -3,997,000USD | 221,926,000USD | 74,361,000USD | 33,347,000USD |
| Dividends Paid | — | — | -52,567,000USD | — | -710,000USD | -747,000USD | -37,275,000USD | -4,385,000USD |
| Change To Liabilities | — | — | — | 1,023,000USD | 2,796,000USD | 1,859,000USD | 1,838,000USD | 3,490,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -61,864,000USD | -63,893,000USD | 173,619,000USD | -4,475,000USD | 8,602,000USD |
| Unclassified Operating Cash Flow | — | — | — | — | -78,122,000USD | 86,189,000USD | -4,303,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| FY 2025Yearly · 2025-12-31 | Product | Collaboration Revenue | 128,000 | USD | 0001104659-26-010664 |
| FY 2025Yearly · 2025-12-31 | Product | Product | 51,823,000 | USD | 0001104659-26-010664 |
| Q2 2025Quarterly · 2025-06-30 | Product | Collaboration Revenue | 64,000 | USD | 0001558370-25-010177 |
| Q2 2025Quarterly · 2025-06-30 | Product | Product | 13,395,000 | USD | 0001558370-25-010177 |
| Q1 2025Quarterly · 2025-03-31 | Product | Collaboration Revenue | 64,000 | USD | 0001104659-26-055256 |
| Q1 2025Quarterly · 2025-03-31 | Product | Product | 10,634,000 | USD | 0001104659-26-055256 |
| FY 2024Yearly · 2024-12-31 | Product | Collaboration Revenue | 262,000 | USD | 0001104659-26-010664 |
| FY 2024Yearly · 2024-12-31 | Product | Product | 63,461,000 | USD | 0001104659-26-010664 |
| Q4 2024Quarterly · 2024-12-31 | Product | Collaboration Revenue | 63,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Product | 17,020,000 | USD | Legacy provider |
| Q3 2024Quarterly · 2024-09-30 | Product | Collaboration Revenue | 78,000 | USD | 0001558370-24-015613 |
| Q3 2024Quarterly · 2024-09-30 | Product | Otx Tic Product | 78,000 | USD | 0001558370-24-015613 |
| Q3 2024Quarterly · 2024-09-30 | Product | Product | 15,347,000 | USD | 0001558370-24-015613 |
| Q2 2024Quarterly · 2024-06-30 | Product | Collaboration Revenue | 62,000 | USD | 0001558370-24-011202 |
| Q2 2024Quarterly · 2024-06-30 | Product | Otx Tic Product | 62,000 | USD | 0001558370-24-011202 |
| Q2 2024Quarterly · 2024-06-30 | Product | Product | 16,379,000 | USD | 0001558370-24-011202 |
| Q1 2024Quarterly · 2024-03-31 | Product | Collaboration Revenue | 59,000 | USD | 0001558370-24-007065 |
| Q1 2024Quarterly · 2024-03-31 | Product | Otx Tic Product | 59,000 | USD | 0001558370-24-007065 |
| Q1 2024Quarterly · 2024-03-31 | Product | Product | 14,715,000 | USD | 0001558370-24-007065 |
| FY 2023Yearly · 2023-12-31 | Product | Collaboration Revenue | 573,000 | USD | 0001558370-24-002902 |
| FY 2023Yearly · 2023-12-31 | Product | Otx Tic Product | 573,000 | USD | 0001558370-24-002902 |
| FY 2023Yearly · 2023-12-31 | Product | Product | 57,870,000 | USD | 0001558370-24-002902 |
| Q3 2023Quarterly · 2023-09-30 | Product | Collaboration Revenue | 131,000 | USD | 0001558370-24-015613 |
| Q3 2023Quarterly · 2023-09-30 | Product | Otx Tic Product | 131,000 | USD | 0001558370-24-015613 |
| Q3 2023Quarterly · 2023-09-30 | Product | Product | 14,950,000 | USD | 0001558370-24-015613 |
| FY 2022Yearly · 2022-12-31 | Product | Collaboration Revenue | 1,037,000 | USD | 0001558370-25-002000 |
| FY 2022Yearly · 2022-12-31 | Product | Product | 50,457,000 | USD | 0001558370-25-002000 |
| Q3 2022Quarterly · 2022-09-30 | Product | Collaboration Revenue | 52,000 | USD | 0001558370-23-017989 |
| Q3 2022Quarterly · 2022-09-30 | Product | Otx Tic Product | 52,000 | USD | 0001558370-23-017989 |
| Q3 2022Quarterly · 2022-09-30 | Product | Product | 11,913,000 | USD | 0001558370-23-017989 |
| FY 2021Yearly · 2021-12-31 | Product | Otx Tic Product | 0 | USD | 0001558370-24-002902 |
| FY 2021Yearly · 2021-12-31 | Product | Product | 43,522,000 | USD | 0001558370-24-002902 |
| FY 2020Yearly · 2020-12-31 | Product | Otx Tic Product | 0 | USD | 0001558370-23-002908 |
| FY 2020Yearly · 2020-12-31 | Product | Product | 17,403,000 | USD | 0001558370-23-002908 |
| FY 2016Yearly · 2016-12-31 | Product | Collaboration Revenue | 42,000 | USD | 0001558370-19-001659 |
| FY 2016Yearly · 2016-12-31 | Product | Product | 1,845,000 | USD | 0001558370-19-001659 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.